NDC 65483-093

RIDAURA

Auranofin

RIDAURA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Prometheus Laboratories Inc.. The primary component is Auranofin.

• Product ID: 65483-093_6008addc-7f8e-45bb-8aec-54dd54a788ac
• NDC: 65483-093
• Product Type: Human Prescription Drug
• Proprietary Name: RIDAURA
• Generic Name: Auranofin
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 1985-04-24
• Marketing Category: NDA / NDA
• Application Number: NDA018689
• Labeler Name: Prometheus Laboratories Inc.
• Substance Name: AURANOFIN
• Active Ingredient Strength: 3 mg/1
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 65483-093-06

60 CAPSULE in 1 BOTTLE (65483-093-06)

• Marketing Start Date: 1985-04-24
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 65483-093-06 [65483009306]

RIDAURA CAPSULE

• Marketing Category: NDA
• Application Number: NDA018689
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1985-04-24
• Inactivation Date: 2019-11-13

Drug Details

Active Ingredients

Ingredient	Strength
AURANOFIN	3 mg/1

OpenFDA Data

• SPL SET ID: 05c34ddf-a0f7-4267-83f5-d02be3defc37
• Manufacturer:
  • Prometheus Laboratories Inc.
• UNII:
  • 3H04W2810V
• RxNorm Concept Unique ID - RxCUI:
  • 197386
  • 213510
• UPC Code:
  • 0365483093063

Medicade Reported Pricing

65483009306 RIDAURA 3 MG CAPSULE

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "RIDAURA" or generic name "Auranofin"

NDC	Brand Name	Generic Name
54766-093	RIDAURA	auranofin
65483-093	RIDAURA	auranofin